(6aR,9R,10aR)-N-((2R,5S,10aS,10bS)-10b-hydroxy-5-isobutyl-2-isopropyl-3,6-dioxooctahydro-2H-oxazolo[3,2-a]pyrrolo[2,1-c]pyrazin-2-yl)-7-methyl-4,6,6a,7,8,9,10,10a-octahydroindolo[4,3-fg]quinoline-9-carboxamide; (5'?,10?)-9,10-Dihydro-12'-hydroxy-2'-(1-methylethyl)-5'-(2-methylpropyl)ergotaman-3',6',18-trione; 9,10-Dihydro-?-ergocryptine; 9,10-Dihydroergocryptine; 9,10-Dihydroergokryptine; Almirid; Dihydro-?-ergocriptine; Dihydro-?-ergocryptin; Dihydroergocriptine; Dihydroergocryptine; ?-Dihydroergokryptine
Dihydro-a-Ergocryptine is a fully characterized chemical compound used as a reference standard of API Ergotamine. The standard offered is compliant with regulatory guidelines. Dihydro-a-Ergocryptine is used for analytical method development, method validation (AMV), and Quality Controlled (QC) applications during synthesis and formulation stages of drug development and serves as a reference standard for traceability against pharmacopeial standards (USP or EP). Axios Research products are intended for analytical purposes only and are not for human use. CAS - 25447-66-9